文献速递头颈甲状腺与浅表CT

基于CT的影像组学模型鉴别甲状腺结节良恶性:多中心开发与验证研究

CT-Based Radiomics Models for Differentiation of Benign and Malignant Thyroid Nodules: A Multicenter Development and Validation Study.
PubMed 文献 · AJR Am J Roentgenol · 2024-05-01

本研究为回顾性多中心研究,纳入两中心378例患者408枚切除甲状腺结节,基于术前多期颈部CT提取影像组学特征,构建联合临床、形态学CT及多期CT影像组学的模型,并在外部验证集中评估。联合模型外部验证AUC为0.923,阈值下敏感度84.0%、特异度94.1%、准确率87.0%,AUC显著高于其他各模型。

要点

  • 联合模型纳入年龄、囊性变、边缘中断征、异常颈部淋巴结及28个影像组学特征。
  • 外部验证集联合模型AUC 0.923,敏感度84.0%、特异度94.1%、准确率87.0%。
  • 联合模型AUC显著高于常规模型(0.827)及多期CT影像组学模型(0.824)等(均p<.05)。

核心结论

  • 联合临床、形态学CT及多期CT影像组学特征的模型在鉴别甲状腺结节良恶性方面表现出稳健性能,可能有助于指导CT检出甲状腺结节的进一步管理。

研究设计与样本

  • 回顾性多中心研究,两中心共378例患者(平均年龄46.3±13.9岁;男86例、女292例)408枚切除甲状腺结节(良性145枚、恶性263枚);中心1(293枚,2018年1月至2022年12月)分为训练集206枚和内部验证集87枚,中心2(115枚,2020年1月至2022年12月)为外部验证集;术前接受多期颈部CT(平扫、动脉期、静脉期)。

诊断标准与关键数值

  • 外部验证集中,联合模型在训练集得出的最优阈值下,AUC为0.923,敏感度84.0%,特异度94.1%,准确率87.0%;联合模型AUC显著高于常规模型(0.827)、平扫CT影像组学模型(0.847)、动脉期CT影像组学模型(0.826)、静脉期CT影像组学模型(0.773)和多期CT影像组学模型(0.824)(均p<.05)。

临床应用与阅片要点

  • 联合模型纳入患者年龄、三个形态学特征(囊性变、「边缘中断」征、异常颈部淋巴结)和28个影像组学特征(来自三个期相);外部验证集中联合模型校准曲线Brier评分最低(最佳),决策曲线分析中联合模型在大多数阈值概率范围内净获益最高;作者认为联合影像组学模型可能有助于指导CT检出甲状腺结节的进一步管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. CT is increasingly detecting thyroid nodules. Prior studies indicated a potential role of CT-based radiomics models in characterizing thyroid nodules, although these studies lacked external validation. OBJECTIVE. The purpose of this study was to develop and validate a CT-based radiomics model for the differentiation of benign and malignant thyroid nodules. METHODS. This retrospective study included 378 patients (mean age, 46.3 ± 13.9 [SD] years; 86 men, 292 women) with 408 resected thyroid nodules (145 benign, 263 malignant) from two centers (center 1: 293 nodules, January 2018 to December 2022; center 2: 115 nodules, January 2020 to December 2022) who underwent preoperative multiphase neck CT (noncontrast, arterial, and venous phases). Nodules from center 1 were divided into training (n = 206) and internal validation (n = 87) sets; all nodules from center 2 formed an external validation set. Radiologists assessed nodules for morphologic CT features. Nodules were manually segmented on all phases, and radiomic features were extracted. Conventional (clinical and morphologic CT), noncontrast CT radiomics, arterial phase CT radiomics, venous phase CT radiomics, multiphase CT radiomics, and combined (clinical, morphologic CT, and multiphase CT radiomics) models were established using feature selection methods and evaluated by ROC curve analysis, calibration-curve analysis, and decision-curve analysis. RESULTS. The combined model included patient age, three morphologic features (cystic change, "edge interruption" sign, abnormal cervical lymph nodes), and 28 radiomic features (from all three phases). In the external validation set, the combined model had an AUC of 0.923, and, at an optimal threshold derived in the training set, sensitivity of 84.0%, specificity of 94.1%, and accuracy of 87.0%. In the external validation set, the AUC was significantly higher for the combined model than for the conventional model (0.827), noncontrast CT radiomics model (0.847), arterial phase CT radiomics model (0.826), venous phase CT radiomics model (0.773), and multiphase CT radiomics model (0.824) (all p < .05). In the external validation set, the calibration curves indicated the lowest (i.e., best) Brier score for the combined model; in the decision-curve analysis, the combined model had the highest net benefit for most of the range of threshold probabilities. CONCLUSION. A combined model incorporating clinical, morphologic CT, and multiphase CT radiomics features exhibited robust performance in differentiating benign and malignant thyroid nodules. CLINICAL IMPACT. The combined radiomics model may help guide further management for thyroid nodules detected on CT.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lin S, Gao M, Yang Z, et al. CT-Based Radiomics Models for Differentiation of Benign and Malignant Thyroid Nodules: A Multicenter Development and Validation Study. AJR Am J Roentgenol. 2024. PMID: 38691415. doi:10.2214/AJR.24.31077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。